PTGS2 and osteoarthritis: Further, our in vivo data also show that the majority of COX2+ cells were subchondral osteoblasts and osteocytes during the progression of MetS-OA, and selective COX2 celecoxib treatment markedly alleviated pathological subchondral bone thickening and osteoarthritis progression.